Biotechnology News

July 24, 2014

ZHANGJIAJIE, China--(BUSINESS WIRE)--Jinchi Biotech Ltd., During July 10th - 12th, 2014, a group of 40 SHINIQUE VIP Customers, formed by managers of local or national beauty salon chains from all over China attended the second 'SHINIQUE Health...

July 24, 2014

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: Milestone payments and sale of product rights bring profit in second quarter Second quarter 2014, April - June -- Net sales for April – June 2014 amounted to SEK 32 (12) million. -- Earnings after...

July 24, 2014

MELBOURNE, Australia--(BUSINESS WIRE)--Gilead Sciences, Inc. (NASDAQ:GILD) announced today at the 20th International AIDS Conference in Melbourne, Australia, a new agreement with the Medicines Patent Pool (MPP) to expand access to Gilead’s...

July 24, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it will acquire Cognigen Corporation of Buffalo, New York, a leading provider of clinical trial data analysis.

July 24, 2014

NEW YORK & OSAKA, Japan--(BUSINESS WIRE)--Bristol-Myers Squibb and Ono Pharmaceutical Co., Ltd. Announce Strategic Immuno-Oncology Collaboration in Japan, South Korea and Taiwan

July 23, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (NASDAQ:CSII) will host a live webcast of its fiscal 2014 fourth-quarter conference call on Wednesday, August 6, 2014, at 3:45 p.m. CT (4:45 p.m. ET). David Martin, President...

July 23, 2014

FRAMINGHAM, Mass.--(BUSINESS WIRE)--rEVO Biologics, Inc., a subsidiary of LFB Biotechnologies, today announced the enrollment of the first patient in its Phase 3 clinical trial of ATryn® [antithrombin (Recombinant)], for the treatment of...

July 23, 2014

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte Corporation (Nasdaq: INCY) today announced top-line results from RELIEF, a randomized, double-blind clinical trial designed to compare symptom improvement in 110 patients with polycythemia vera (PV)...

July 23, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended June 30, 2014. Total revenues for the second quarter of 2014 increased to $6.53 billion compared to $2.77...

July 23, 2014

SAN DIEGO--(BUSINESS WIRE)--Illumina Reports Strong Results for Second Quarter of Fiscal Year 2014

July 23, 2014

ARDEN HILLS, Minn.--(BUSINESS WIRE)--IntriCon Corporation (NASDAQ: IIN), a designer, developer, manufacturer and distributor of miniature and micro-miniature body-worn devices, today announced financial results for its second quarter ended June...

July 23, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), an innovative company specialized in the development of drugs in orphan oncology diseases, and Topotarget A/S (NASDAQ OMX...

July 23, 2014

SHANGHAI & BETHLEHEM, Pa.--(BUSINESS WIRE)--Personalized Chemotherapy Tests Cleared for Use in China. Fosun Diagnostics receives CFDA Clearance for the Saladax MyCare™ Portfolio of Chemotherapy Exposure Optimization Tests.

July 23, 2014

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Kansas seeks to become model for nation -- Treating the whole person using advanced technological solution at 23 mental health centers.

July 23, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck today announced that the Board of Directors has declared a quarterly dividend of $0.44 per share of the company’s common stock for the fourth quarter of 2014.

July 23, 2014

MARKHAM, Ontario--(BUSINESS WIRE)--Philips North America today launched the second annual Philips Innovation Fellows competition, and released the findings from its 2014 North America Innovation Report. According to the survey, three in five...

July 23, 2014

ANDOVER, Mass.--(BUSINESS WIRE)--Philips North America today announced the launch of the second annual Philips Innovation Fellows competition, in conjunction with the release of its 2014 North America Innovation Report. According to the report,...

July 23, 2014

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, LLC announced that it has commenced clinical and analytical studies to evaluate the company’s FilmArray Meningitis/Encephalitis (ME) Panel, with plans to seek FDA clearance.

July 23, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Zydelig® (idelalisib) 150 mg tablets for the treatment of three B-cell blood cancers. Zydelig...

July 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) announced that the European Commission (EC) has granted marketing authorization for PLEGRIDYTM (peginterferon beta-1a) as a treatment for adults with relapsing-remitting multiple...

July 23, 2014

PITTSBURGH--(BUSINESS WIRE)--HeadSmart™Labs, a Healy Ventures LLC company, today announced its official launch to advance research methods that will aid in the prevention of head and neck injuries sustained by athletes who wear helmets during...

July 23, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corp Q2 YTD order growth rises 151% over 2013 as trial sponsors choose the PHT electronic clinical outcome assessment (eCOA) System for 25+ new trials to collect and report on patient-driven eData

July 23, 2014

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its partner GlaxoSmithKline (GSK) plc has announced global revenue for Promacta™/Revolade™ for the second quarter ended June 30, 2014 of $92...

July 23, 2014

SAN DIEGO--(BUSINESS WIRE)--La Jolla Pharmaceutical Company Announces Pricing of Underwritten Offering of Common Stock

July 23, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals’ PV-10 Clinical Data on the Treatment of Melanoma to Be Presented at European Society for Medical Oncology 2014 Congress

July 23, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will report its second quarter 2014 financial results on July 31, 2014, after close of market.

July 23, 2014

CINCINNATI--(BUSINESS WIRE)--Camargo Pharmaceutical Services expands its research team and therapeutic expertise with the addition of Dr. Wen-Yee Choi, Dr. Jillian Orans, Dr. Vien Lai and Kathryn Kemme.

July 23, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against multidrug-resistant bacteria, today...

July 23, 2014

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., (NYSE MKT:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical...

July 23, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced the online publication of scientific data for DX-2930, an investigational fully human monoclonal antibody inhibitor of plasma kallikrein (pKal), in two peer-reviewed...

July 23, 2014

SAN DIEGO--(BUSINESS WIRE)--bioTheranostics, Inc., the leading genomic solutions provider for cancer diagnosis, announced the addition of Ramesh Hariharan, Ph.D., to senior management as vice president of marketing.

July 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gen9, Inc., the pioneer in the development of scalable technologies for synthesizing and assembling DNA, today announced the commercial launch of GeneByte Plus™ DNA constructs, synthesized at lengths ranging...

July 23, 2014

BEDMINSTER, N.J. & RESEARCH TRIANGLE PARK, N.C. & NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) announced today that its second quarter 2014 financial results will be released after the market closes on...

July 23, 2014

WEST HAVEN, Conn.--(BUSINESS WIRE)--President, Dr. Anil Diwan, was invited to participate in the CEO Roundtable on the Expanded Role of CFO, and CEO of the Year Felicitation Event held at the New York Stock Exchange on July 17, 2014.

July 23, 2014

PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO), a global company focused on saving lives, alleviating suffering, and contributing to the economics of healthcare by focusing on the world's leading acute/intensive care...

July 23, 2014

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (“Eagle” or “the Company”) (Nasdaq:EGRX) today announced that the U. S. Food and Drug Administration (FDA) has approved Ryanodex® (dantrolene sodium) for injectable suspension...

July 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--BIOGEN IDEC SECOND QUARTER 2014 REVENUES INCREASE 40% TO $2.4 BILLION; COMPANY RAISES FINANCIAL GUIDANCE FOR THE YEAR

July 23, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics Announces Closing of Initial Public Offering

July 23, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 28, 2014, the first full quarter including the Life...

July 23, 2014

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2014 on Wednesday, July 30, 2014 after the Board Meeting. The results will be available on the Company’s website...

July 23, 2014

CAMBRIDGE, England--(BUSINESS WIRE)--Biosceptre, the oncology company developing antibody products that target the nf-P2X7 receptor, announces positive results from its Phase I trial to assess the safety and tolerability of BIL-010t (formerly...

July 22, 2014

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) will host a conference call and live audio webcast on Tuesday, July 29, 2014, at 8:30 a.m. ET to report financial results for the 4th quarter and FY 2014.

July 22, 2014

RICHMOND, Va.--(BUSINESS WIRE)--American International Biotechnology, LLC (“AIBioTech”) recently reached a settlement with the U.S. Department of Justice to fully resolve allegations about a contract sales agent’s actions in connection with...

July 22, 2014

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced top-line results from the ExteNET study of its investigational drug neratinib, a Phase III trial in adjuvant breast cancer.

July 22, 2014

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology announced that its license agreement with Pfizer for the investigational drug neratinib (PB272) has been amended.